Biotech Scientific Operations · Drug Discovery · Translational Research

Alina Ustiugova, PhD

Biology Analyst & Molecular Biology Scientist

I work across AI-enabled drug discovery, therapeutic strategy, translational research, molecular biology, and immunology — taking scientific questions from initial brief through structured analysis to evidence-based recommendation.

Alina Ustiugova
Abu Dhabi, UAE
Profile

Scientific research, therapeutic strategy, and execution.

My work combines biological judgment with structured scientific operations and cross-functional collaboration.

I am a biology analyst and molecular biology scientist with nine years of experience across AI-enabled drug discovery and academic research.

My work spans target identification, biomarker discovery, indication prioritization, drug repurposing, mechanism-of-action research, and clinical-trial analysis. I currently lead therapeutic research projects from initial scientific brief through evidence synthesis, biological interpretation, hypothesis prioritization, and client-ready recommendation.

My experimental background includes immunology, molecular biology, genetics, CRISPR/Cas9, cell culture, PCR/qPCR, flow cytometry, ELISA, western blotting, and translational research.

Current role Biology Analyst
Current organization Insilico Medicine
Current portfolio ~US$1M research programs
Location Abu Dhabi, UAE
Publications 35 research outputs
Expertise

Areas of scientific focus.

Therapeutic research from biological hypothesis through analysis, prioritization, and recommendation.

Target & Biomarker Discovery

Therapeutic target identification, biomarker discovery, biological plausibility assessment, and evidence-based prioritization.

Multi-omics Analysis

Biological interpretation of genomic, transcriptomic, proteomic, and other omics datasets.

AI-enabled Research

Application and evaluation of AI/ML approaches for biomedical research, evidence synthesis, and drug discovery.

Drug Discovery Strategy

Indication prioritization, drug repurposing, mechanism-of-action research, and therapeutic strategy.

Immunology & Molecular Biology

Experimental and translational biology, including immunology, genetics, CRISPR/Cas9, and molecular biology.

Scientific Operations & Communication

Project scoping, work plans, reports, presentations, stakeholder communication, and cross-functional execution.

Experience

Professional experience.

2024 — Present

Biology Analyst

Insilico Medicine · Abu Dhabi, UAE

Lead therapeutic research projects from initial scientific brief through evidence synthesis, platform-based analysis, biological interpretation, hypothesis prioritization, and client-ready recommendation. Own a portfolio of pharma-sponsored, academic, and internal R&D programs totaling approximately US$1M.

2022 — 2024

Analyst / Data Curator

Insilico Medicine · Abu Dhabi, UAE

Evaluated clinical trial designs and outcomes, produced forecasting reports for pharmaceutical clients, curated more than 10,000 clinical trial outcomes, interpreted ML-generated knowledge graphs, and developed structured biomedical data workflows and quality-control guidelines.

2017 — 2022

Senior Researcher

Engelhardt Institute of Molecular Biology RAS

Led research projects from hypothesis development and grant preparation through experimental execution, interpretation, publication, and scientific communication. Secured four research grants and worked across immunology, molecular biology, genetics, and CRISPR/Cas9 genome editing.

Research

Selected publications.

Selected work from a record of articles, preprints, and conference abstracts across therapeutic discovery, immunology, molecular biology, and translational research.

2026

Autophagy regulator ATG7 links lipid metabolism to cell-fate decisions in kidney tubule health and disease

Nature Communications
2026

Evaluation of (Z)-endoxifen as a potential therapy for glioblastoma multiforme through computational and experimental analyses

Scientific Reports
2025

From clock to clock: Therapeutic target discovery for aging and age-related diseases

Ageing Research Reviews
2024

Designing a multi-serotype Dengue virus vaccine: an in silico approach to broad-spectrum immunity

bioRxiv
2022

CRISPR/Cas9 genome editing demonstrates functionality of the autoimmunity-associated SNP rs12946510

BBA — Molecular Basis of Disease
2019

Multi-dimensional immunoproteomics coupled with in vitro recapitulation of oncogenic NRASQ61R identifies diagnostically relevant autoantibody biomarkers in thyroid neoplasia

Cancer Letters
Education

Academic background.

2020 — 2025

PhD in Molecular Biology

Engelhardt Institute of Molecular Biology RAS

Thesis: Functional analysis of non-coding single nucleotide polymorphisms associated with human autoimmune diseases.

2018 — 2020

MSc in Biology

Lomonosov Moscow State University

Specialization: Immunology

2014 — 2018

BSc in Biology

Lomonosov Moscow State University

Specialization: Immunology

Research, collaboration, and scientific opportunities.

For professional or research-related inquiries, feel free to contact me by email or connect through LinkedIn, Google Scholar, or ORCID.